Item 1A. RISK FACTORS

There have been no material changes in the company's risk factors from those disclosed in the company's Annual Report on Form 10-K for the year ended December 31, 2024, filed with the SEC on February 27, 2025.


Item 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

Issuer Purchases of Equity Securities


Period	Total Number of Class A Shares Purchased		Average Price Paid per Share		Total Number of Class A Shares Purchased as Part of Publicly Announced Plans or Programs (1)	Maximum Approximate Value of Shares That May Yet Be Purchased Under the Plans or Programs (in millions)
April 1 to April 30	32,866	(2)	$	253.51	32,265	$	2,991.8
May 1 to May 31	77	(3)	271.70		—	2,991.8
June 1 to June 30	1,776	(3)	269.66		—	2,991.8
Total	34,719	(4)			32,265

(1)On December 5, 2024, CME Group announced that its board of directors approved a share repurchase program under which CME Group is authorized to repurchase up to $3.0 billion of its outstanding Class A common stock, par value $0.01 per share (the common stock). The share repurchase program has no expiration date.

(2)Includes 601 shares of Class A common stock surrendered to satisfy employees' tax obligations upon the vesting of restricted stock.

(3)Consists solely of shares of Class A common stock surrendered to satisfy employees' tax obligations upon the vesting of restricted stock.

(4)Includes 2,454 shares of Class A common stock surrendered to satisfy employees' tax obligations upon the vesting of restricted stock.

Previous: Item 4. CONTROLS AND PROCEDURES · Next: Item 5. OTHER INFORMATION